These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17702894)

  • 1. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
    Zenzmaier C; Sampson N; Plas E; Berger P
    Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene.
    Wang K; Jin S; Fan D; Wang M; Xing N; Niu Y
    PLoS One; 2017; 12(2):e0172233. PubMed ID: 28196103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits the proliferation of benign prostatic epithelial cells.
    Wang Z; Xiao X; Ge R; Li J; Johnson CW; Rassoulian C; Olumi AF
    PLoS One; 2017; 12(3):e0173335. PubMed ID: 28253329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic exercises ameliorate benign prostatic hyperplasia via IGF-1/IGF-1R/ERK/AKT signalling pathway in prostate tissue of high-fat-diet-fed mice with insulin resistance.
    Nian L; Shukang G; Shasha W; Xiangyun L
    Steroids; 2021 Nov; 175():108910. PubMed ID: 34461103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of Rab27B in prostatic epithelial cells of benign prostatic hyperplasia alters intercellular communication.
    Dai Y; Ai B; Liu Y; Pascal LE; Wang Z; Dhir R; Sun X; Jiang Y
    Int J Biochem Cell Biol; 2021 Feb; 131():105898. PubMed ID: 33285290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
    Giri D; Ropiquet F; Ittmann M
    J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells.
    Grant ES; Ross MB; Ballard S; Naylor A; Habib FK
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3252-7. PubMed ID: 9745438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
    Wang Z; Olumi AF
    Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
    Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
    Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.
    Wang YZ; Wong YC
    Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
    Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.